+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Therapeutic Plasma Exchange Market By Technique (Centrifugation v/s Membrane Separation), By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders), By Gender (Male v/s Female), By End Use, By Region, Forecast & Opportunities, 2025

  • ID: 5022596
  • Report
  • May 2020
  • Region: Global
  • 112 pages
  • TechSci Research
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Market for Therapeutic Plasma Exchange is Anticipated to Grow at Brisk Rate During the Forecast Period.

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cerus Corporation
  • Fresenius Medical Care
  • HemaCare Corporation
  • Medica S.p.A.
  • Nikkiso Co., Ltd.
  • MORE
The global market for therapeutic plasma exchange is anticipated to grow at brisk rate during the forecast period. Therapeutic plasma exchange or plasmapheresis is a procedure to filter blood and remove harmful antibodies present in plasma by separating it from blood with the assistance of techniques called centrifugation or membrane separation. Therapeutic plasma exchange or Plasmapheresis, the process of replacing blood in the body, has witnessed significant rise in the demand on account of increasing chronic diseases, for instance, Guillain Barre Syndrome (GBS); thereby, positively influencing the therapeutic plasma exchange market across the globe. However, plasmapheresis is costly enough, which is expected to hamper the growth of the market.

The Global Therapeutic Plasma Exchange Market is segmented on the basis of technique, indication, gender, end-use and region. The Indication segment is further divided into neurological disorders, renal disorders, hematology disorders, metabolic disorders, out of which, neurological disorders is expected to be the most dominant segment as the number of cases of chronic and fatal neurological disorders are increasing day by day.

North America held the largest market share in the year of 2019 due to the pre-existing pharma & biotech companies and the surge in research and development activities in the region. On the other hand, Asia-Pacific is expected to be the fastest growing region as the leading companies of therapeutic plasma exchange in the region have now started investing in the plasmapheresis procedures.

Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc., are some of the prominent therapeutic plasma exchange companies of the world. To maintain their position in the Global Therapeutic Plasma Exchange Market, the leading players are adopting several organic and inorganic strategies such as mergers, acquisitions, etc.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and estimate the market size of the Global Therapeutic Plasma Exchange Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global Therapeutic Plasma Exchange Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global Therapeutic Plasma Exchange Market based on technique, indication, gender, end-use, company and region.
  • To identify dominant region or segment in the Global Therapeutic Plasma Exchange Market.
  • To identify drivers and challenges for the Global Therapeutic Plasma Exchange Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Therapeutic Plasma Exchange Market.
  • To conduct pricing analysis for the Global Therapeutic Plasma Exchange Market.
  • To identify and analyze the profile of leading players operating in the Global Therapeutic Plasma Exchange Market.
  • To identify key sustainable strategies adopted by market players in the Global Therapeutic Plasma Exchange Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals and clinics using therapeutic plasma exchange techniques across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals and clinics using therapeutic plasma exchange techniques which could not be identified due to the limitations of secondary research. The author analyzed the hospitals and clinics using therapeutic plasma exchange techniques, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Therapeutic Plasma Exchange Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. They sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Hospitals, clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic plasma exchange
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics using therapeutic plasma exchange techniques, suppliers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Therapeutic Plasma Exchange Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Technique:
  • Centrifugation
  • Membrane Separation
Market, By Indication:
  • Neurological Disorders
  • Renal Disorders
  • Hematology Disorders
  • Metabolic Disorders
Market, By Gender:
  • Male
  • Female
Market, By End-Use:
  • Hospitals
  • Clinics
  • Others
Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • South Korea
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape
  • Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Plasma Exchange Market.
Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. If you buy the ‘Multi-user’ License of this report before June 2020, you will get a free update in form of market data excel sheet within 3 to 6 months of your purchase on request.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cerus Corporation
  • Fresenius Medical Care
  • HemaCare Corporation
  • Medica S.p.A.
  • Nikkiso Co., Ltd.
  • MORE
1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer
4.1. Brand Awareness (Aided/Unaided)
4.2. Product Awareness
4.3. Customer Satisfaction Analysis
4.4. Unmet Needs/Challenges

5. Global Therapeutic Plasma Exchange Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (Centrifugation v/s Membrane Separation)
5.2.2. By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders)
5.2.3. By Gender (Male v/s Female)
5.2.4. By End Use (Hospitals, Clinics, Others)
5.2.5. By Company (2019)
5.2.6. By Region
5.3. Product Market Map

6. Asia-Pacific Therapeutic Plasma Exchange Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Indication
6.2.3. By End Use
6.2.4. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Therapeutic Plasma Exchange Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technique
6.3.1.2.2. By Indication
6.3.1.2.3. By End Use
6.3.2. India Therapeutic Plasma Exchange Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technique
6.3.2.2.2. By Indication
6.3.2.2.3. By End Use
6.3.3. Australia Therapeutic Plasma Exchange Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technique
6.3.3.2.2. By Indication
6.3.3.2.3. By End Use
6.3.4. Japan Therapeutic Plasma Exchange Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technique
6.3.4.2.2. By Indication
6.3.4.2.3. By End Use
6.3.5. South Korea Therapeutic Plasma Exchange Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technique
6.3.5.2.2. By Indication
6.3.5.2.3. By End Use

7. Europe Therapeutic Plasma Exchange Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Indication
7.2.3. By End Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Therapeutic Plasma Exchange Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Indication
7.3.1.2.3. By End Use
7.3.2. Germany Therapeutic Plasma Exchange Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Indication
7.3.2.2.3. By End Use
7.3.3. United Kingdom Therapeutic Plasma Exchange Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Indication
7.3.3.2.3. By End Use
7.3.4. Italy Therapeutic Plasma Exchange Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technique
7.3.4.2.2. By Indication
7.3.4.2.3. By End Use
7.3.5. Spain Therapeutic Plasma Exchange Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technique
7.3.5.2.2. By Indication
7.3.5.2.3. By End Use

8. North America Therapeutic Plasma Exchange Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Indication
8.2.3. By End Use
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Therapeutic Plasma Exchange Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Indication
8.3.1.2.3. By End Use
8.3.2. Mexico Therapeutic Plasma Exchange Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Indication
8.3.2.2.3. By End Use
8.3.3. Canada Therapeutic Plasma Exchange Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Indication
8.3.3.2.3. By End Use

9. South America Therapeutic Plasma Exchange Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Indication
9.2.3. By End Use
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Therapeutic Plasma Exchange Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Indication
9.3.1.2.3. By End Use
9.3.2. Argentina Therapeutic Plasma Exchange Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Indication
9.3.2.2.3. By End Use
9.3.3. Colombia Therapeutic Plasma Exchange Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Indication
9.3.3.2.3. By End Use

10. Middle East and Africa Therapeutic Plasma Exchange Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique
10.2.2. By Indication
10.2.3. By End Use
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Therapeutic Plasma Exchange Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Indication
10.3.1.2.3. By End Use
10.3.2. Saudi Arabia Therapeutic Plasma Exchange Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Indication
10.3.2.2.3. By End Use
10.3.3. UAE Therapeutic Plasma Exchange Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Indication
10.3.3.2.3. By End Use

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape
13.1. Haemonetics Corporation
13.2. Fresenius Medical Care
13.3. Terumo BCT, Inc.
13.4. Baxter International Inc.
13.5. Asahi Kasei Medical Co., Ltd.
13.6. Kawasumi Laboratories Inc.
13.7. B. Braun Melsungen AG
13.8. HemaCare Corporation
13.9. Medica S.p.A.
13.10. Cerus Corporation
13.11. Nikkiso Co., Ltd.
13.12. Miltenyi Biotec
13.13. Therakos Incorporation
13.14. Fenwal Incorporation
13.15. Kaneka Corporation

14. Strategic Recommendations

15. About Us & Disclaimer
Note: Product cover images may vary from those shown
3 of 3
  • Haemonetics Corporation
  • Fresenius Medical Care
  • Terumo BCT, Inc.
  • Baxter International Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Kawasumi Laboratories Inc.
  • B. Braun Melsungen AG
  • HemaCare Corporation
  • Medica S.p.A.
  • Cerus Corporation
  • Nikkiso Co., Ltd.
  • Miltenyi Biotec
  • Therakos Incorporation
  • Fenwal Incorporation
  • Kaneka Corporation
Note: Product cover images may vary from those shown
Adroll
adroll